Current role
Biotechnology · Healthcare
Board Member
2024-02-08–present
Mark C. McKenna
Board Member
BridgeBio Oncology Therapeutics, Inc. (BBOT)Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Oncology Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBOT alertsAbout Mark C. McKenna
Mark C. McKenna is recorded as Board Member at BridgeBio Oncology Therapeutics, Inc. (BBOT) since February 8, 2024. BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed February 14, 2024 that Mark C. McKenna was appointed Director, effective February 8, 2024. BridgeBio Oncology Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Oncology Therapeutics, Inc. includes Eli Wallace (CEO and Board Member), Pedro Beltran, Ph.D. (CEO and Board Member), Pedro J. Beltran, Ph.D. (CEO and Board Member) and 7 others.
“On February 8, 2024, in connection with the IPO, Mr. Mark C. McKenna and Mr. John Schmid (the "Directors") were appointed to the board of directors of the Company (the "Board").”
Affiliation history
-
Current
2024-02-08–present
Company network
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Neil Kumar, Ph.D. Chairman
- Idan Elmelech CFO, COO
- Uneek Mehra CFO
- Marc Cobo Chief Accounting Officer
- Albert A. Holman, III Board Member
- Bihua Chen Board Member
- Frank McCormick Board Member